DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1
97	潰瘍性大腸炎	0

告示番号

疾患名（ページ内リンク）

臨床試験数

クローン病

潰瘍性大腸炎

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02680756 (ClinicalTrials.gov)	January 2016	9/2/2016	Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD	A Phase 3b, Randomized, Controlled, Multicentre Study With Oral Ferric Maltol (Feraccru) or Intravenous Iron (Ferric Carboxy Maltose; FCM), for the Treatment of Iron Deficiency Anaemia in Subjects With Inflammatory Bowel Disease	Anemia, Iron-Deficiency;Inflammatory Bowel Disease;Crohn's Disease	Drug: Ferric Maltol;Drug: Ferric Carboxy Maltose	Shield Therapeutics	NULL	Completed	18 Years	N/A	All	250	Phase 3	United States;Belgium;France;Germany;Hungary;Spain

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02680756
(ClinicalTrials.gov)

January 2016

9/2/2016

Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD

A Phase 3b, Randomized, Controlled, Multicentre Study With Oral Ferric Maltol (Feraccru) or Intravenous Iron (Ferric Carboxy Maltose; FCM), for the Treatment of Iron Deficiency Anaemia in Subjects With Inflammatory Bowel Disease

Anemia, Iron-Deficiency;Inflammatory Bowel Disease;Crohn's Disease

Drug: Ferric Maltol;Drug: Ferric Carboxy Maltose

Shield Therapeutics

NULL

Completed

18 Years

N/A

All

250

Phase 3

United States;Belgium;France;Germany;Hungary;Spain